The campaign that spreads ResolverRAT through phishing emails uses a remote access trojan and targets the healthcare and pharmaceutical sectors. These emails are written in...
The Indian pharmaceutical industry has approached the Drug Controller General of India (DCGI), filing a plea for relaxation of the...
.png)
The United States Food and Drug Administration (USFDA) has given Zydus Lifesciences final approval to produce medications called Jaythari (Deflazacort).
In a strategic approach to regulating the rapidly growing diagnostic sector, the state health department has made it mandated registration of all diagnostic labs under the Clinical Establishment Act (CEA) 2010. Despite repeated notifications at both
The Indian Pharma Market (IPM) created a conducive growth environment in 2025 for March at 9.3% YoY, which shows a remarkable recovery from the months gone by. Key growth drivers included Cipla...
Cipla made significant progress after obtaining USFDA permission for marketing its generic cancer drug. The USFDA granted Cipla authorization to introduce their paclitaxel protein-bound particles for injectable suspension (albumin-bound) under the br
.png)
The Drug Administration Department of Karnataka has withdrawn defective medications totaling Rs 24.3 lakh from the market as part of a campaign against subpar pharmaceuticals.
.png)
The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.
In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...
Donald Trump's remarks threatening massive tariffs on all imports of pharmaceuticals led to a crash in the Indian pharmaceutical stocks. The news unsettled the Indian...
, CDSCO.jpg)
